NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Saad Z Usmani
Memorial Sloan Kettering Cancer Center - Indore / United States
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4441089
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Saad Z Usmani's MOST POPULAR ARTICLES
1-)
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaSV Rajkumar, MA Dimopoulos, A Palumbo, J Blade, G Merlini, MV Mateos, ...The lancet oncology 15 (12), e538-e548, 201439252014
2-)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaS Kumar, B Paiva, KC Anderson, B Durie, O Landgren, P Moreau, ...The lancet oncology 17 (8), e328-e346, 201617992016
3-)
Daratumumab, lenalidomide, and dexamethasone for multiple myelomaMA Dimopoulos, A Oriol, H Nahi, J San-Miguel, NJ Bahlis, SZ Usmani, ...New England Journal of Medicine 375 (14), 1319-1331, 201613762016
4-)
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1 …JG Berdeja, D Madduri, SZ Usmani, A Jakubowiak, M Agha, AD Cohen, ...The Lancet 398 (10297), 314-324, 202111502021
5-)
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trialS Lonial, BM Weiss, SZ Usmani, S Singhal, A Chari, NJ Bahlis, A Belch, ...The Lancet 387 (10027), 1551-1560, 201610132016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept